Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Anetseder

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|July 4, 2007
[Anesthesia in pediatric neurosurgery]Herbert Trautner, Franz Kehl, Martin Anetseder
The Journal of Pharmacy and Pharmacology|March 16, 2013
Minimally invasive monitoring of skeletal muscle hypermetabolism induced by the phosphodiesterase-III-inhibitor milrinone and sodium fluorideFrank Schuster, Stephan Johannsen, Norbert Roewer, et al.
Muscle & Nerve|January 27, 2015
Effect of caffeine on intrinsic mechanical properties of normal and malignant hyperthermia-susceptible muscleThomas Metterlein, Edmund Hartung, Norbert Roewer, et al.
Case Reports in Anesthesiology|January 24, 2014
A minimal-invasive metabolic test detects malignant hyperthermia susceptibility in a patient after sevoflurane-induced metabolic crisisFrank Schuster, Stephan Johannsen, Norbert Roewer, et al.
Lancet (London, England)|June 6, 2002
Diagnosis of susceptibility to malignant hyperthermia by use of a metabolic testMartin Anetseder, Martin Hager, Clemens R Müller, et al.
Basic & Clinical Pharmacology & Toxicology|April 21, 2006
Pharmacologic modulation of skeletal muscle metabolism: a microdialysis studyFrank Schuster, Petrus Tas, Rainer Müller, et al.
Expert Opinion on Medical Diagnostics|March 15, 2013
Minimally invasive metabolic testing for malignant hyperthermia susceptibility: a systematic review of the methodology and resultsThomas Metterlein, Frank Schuster, Peter Kranke, et al.
BMC Anesthesiology|June 11, 2005
Inhibition of sarcoplasmic Ca2+-ATPase increases caffeine- and halothane-induced contractures in muscle bundles of malignant hyperthermia susceptible and healthy individualsFrank Schuster, Rainer Müller, Edmund Hartung, et al.
European Journal of Anaesthesiology|September 10, 2010
In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced?Thomas Metterlein, Frank Schuster, Peter Kranke, et al.
European Journal of Anaesthesiology|October 8, 2009
Intramuscular injection of malignant hyperthermia trigger agents induces hypermetabolism in susceptible and nonsusceptible individualsThomas Metterlein, Frank Schuster, Peter Kranke, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|July 4, 2007
[Anesthesia in pediatric neurosurgery]Herbert Trautner, Franz Kehl, Martin Anetseder
The Journal of Pharmacy and Pharmacology|March 16, 2013
Minimally invasive monitoring of skeletal muscle hypermetabolism induced by the phosphodiesterase-III-inhibitor milrinone and sodium fluorideFrank Schuster, Stephan Johannsen, Norbert Roewer, et al.
Muscle & Nerve|January 27, 2015
Effect of caffeine on intrinsic mechanical properties of normal and malignant hyperthermia-susceptible muscleThomas Metterlein, Edmund Hartung, Norbert Roewer, et al.
Case Reports in Anesthesiology|January 24, 2014
A minimal-invasive metabolic test detects malignant hyperthermia susceptibility in a patient after sevoflurane-induced metabolic crisisFrank Schuster, Stephan Johannsen, Norbert Roewer, et al.
Lancet (London, England)|June 6, 2002
Diagnosis of susceptibility to malignant hyperthermia by use of a metabolic testMartin Anetseder, Martin Hager, Clemens R Müller, et al.
Basic & Clinical Pharmacology & Toxicology|April 21, 2006
Pharmacologic modulation of skeletal muscle metabolism: a microdialysis studyFrank Schuster, Petrus Tas, Rainer Müller, et al.
Expert Opinion on Medical Diagnostics|March 15, 2013
Minimally invasive metabolic testing for malignant hyperthermia susceptibility: a systematic review of the methodology and resultsThomas Metterlein, Frank Schuster, Peter Kranke, et al.
BMC Anesthesiology|June 11, 2005
Inhibition of sarcoplasmic Ca2+-ATPase increases caffeine- and halothane-induced contractures in muscle bundles of malignant hyperthermia susceptible and healthy individualsFrank Schuster, Rainer Müller, Edmund Hartung, et al.
European Journal of Anaesthesiology|September 10, 2010
In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced?Thomas Metterlein, Frank Schuster, Peter Kranke, et al.
European Journal of Anaesthesiology|October 8, 2009
Intramuscular injection of malignant hyperthermia trigger agents induces hypermetabolism in susceptible and nonsusceptible individualsThomas Metterlein, Frank Schuster, Peter Kranke, et al.
Pageof 3